Chapter 1

Introduction to Metabolomics

In this chapter, you'll learn what metabolomics is and why it is important to scientific discovery, how metabolomics is performed, what the two main profiling methods are in metabolomics, and how sample matrix selection impacts results and interpretation of metabolomics data.

Defining Metabolomics

Metabolomics is the study of metabolites, the small molecule reactants, intermediates, and products of metabolism as well as molecules from diet, exposure, and pharmaceutical origin. Metabolites, along with genes, transcripts, and proteins, represent different but interrelated levels of cellular processes that are organized according to the central dogma of biology. Since metabolites typically represent the terminal step in cellular processes, these molecules are uniquely positioned to receive inputs from the genome, transcriptome, and proteome.

In addition, they are positioned to receive direct input from other factors including the microbiome and the environment (Figure 1). Thus, metabolites not only play a crucial role in mechanisms that directly impact the phenotype, but they also reflect an organism’s real-time biological status more closely than other molecule types. For these reasons, metabolomics is recognized for its ability to reveal deep phenotypic insights that cannot be deduced from genomics, transcriptomics, or proteomics alone.

The ability of metabolomics to ‘complete the picture’ in omics studies has played a major role in advancing scientific discovery, accelerating drug development, validating product quality, and delivering other actionable insights that drive measurable business outcomes and propel research forward.

chapter 1 chart 1

Figure 1. Inputs from cellular molecules and external factors converge on metabolites. The central dogma of biology dictates that cellular processes are carried out by each set of molecules propagating a signal according to inputs from the one(s) that come before it. Metabolites are uniquely placed to receive inputs from each set of cellular molecules as well as from the microbiome and other external factors, making them the closest reflection of the phenotype.

Purpose of this Guide

In this guide we will discuss the basic principles of metabolomics and explore peer reviewed scientific studies that showcase the utility of metabolomics in basic science, translational science, and various applied markets. This guide is written specifically for principal investigators, research scientists, R&D leaders, and innovation strategists, and is intended to show you how metabolomics can amplify study insights beyond traditional omics sciences.

In this guide you will learn:

  1. Metabolomics workflow basics, profiling methods, and sample selection (Chapter 1)
  2. Metabolon’s solutions to challenges associated with metabolomics studies, and how our chemistry-centric (chemo-centric) approach elevates Metabolon-generated data above others (Chapter 2)
  3. Metabolomics for Commercial Applications (Chapter 3)
    • Drug Development
    • Human Nutrition
    • Animal Husbandry and Companion Animal Health
  4. Metabolomics for Translational Studies (Chapter 4)
    • Disease Biomarkers, Mechanisms, and Therapeutic Targets
  5. Metabolomics for Basic Science (Chapter 5)
    • Mechanism
    • Microbiome
    • Population Health
    • Alternative Sample Matrices
  6. How to Design a Metabolomics Study (Chapter 6)

Metabolomics Workflow

Metabolomics is typically performed using either nuclear magnetic resonance (NMR) or liquid chromatography-mass spectrometry (LC-MS). NMR identifies and measures metabolites based on energy emitted from cell nuclei after they are exposed to electromagnetic radiation. This approach has the advantage of keeping the sample intact, which allows alternative follow-up analyses to be performed. However, sample preservation forces a trade-off with sensitivity, which is relatively low with this technique. By contrast, LC-MS offers vastly superior sensitivity and resolution, and thereby greater scientific insight.

In an LC-MS workflow metabolites are isolated from their biological milieu, separated from each other using LC, and analyzed by MS. Mass spectrometers operate by converting the analyte molecules to a charged (ionized) state and then analyzing those ions and any ion fragments that are produced during the ionization process. Metabolites can then be identified by matching the signatures they produce in the MS coupled with their chromatographic (LC) characteristics to a biochemical reference library.

Fast MS scanning speeds enable a high degree of multiplexing and the identification and measurement of hundreds to thousands of compounds in a single analytical run. LC-MS accurately detects metabolites in concentrations that range from picomolar to the molar levels, which enables wide-coverage biochemical profiling.

Profiling Methods

Metabolomics is generally performed using either a targeted or untargeted (global) approach, depending on the study objective or hypothesis being tested. Targeted metabolomics is a quantitative technique that detects and measures a predefined set of metabolites, whereas global metabolomics is semi-quantitative and is used to detect a wide range of metabolites in a biological sample without prior selection (Figure 2).

The broad coverage offered by global metabolomics makes it particularly useful for generating hypotheses and conducting discovery studies, while targeted metabolomics is ideal for validating prior findings or testing a hypothesis associated with a known mechanism or set of biochemical pathways. The features of both profiling methods and their unique applications are demonstrated in the case studies discussed in Chapters 3-5.

chapter 1 chart 2

Figure 2. Summary of targeted and untargeted approaches.

Sample Selection

Numerous sample matrices have been validated in metabolomics workflows including but not limited to various types of tissues, cells, plants, and biological fluids. In some cases, two sample types may be analyzed together to comprehensively evaluate a topic of interest. For example, an investigator looking to characterize mechanisms of irritable bowel disease may profile both serum and feces to determine how alterations in the gut microbiome affect circulating biomarkers of inflammation. Likewise, an investigator studying NAD(H) metabolism may profile serum and muscle tissue because certain metabolites in NAD(H) pathways are more abundant in one matrix over the other and thus profiling both provides a more comprehensive picture of the biological flux. Metabolon’s extensive experience with commonly used and alternative sample matrices are discussed in Chapter 5.

Chapter Takeaways

  • Due to their biological positioning, metabolomics can reveal insight into biological processes that cannot be deduced from other omics sciences alone.
  • Metabolomics is performed using either targeted or untargeted profiling and each approach is uniquely suited to specific types of scientific inquiry.
  • Metabolomics is compatible with numerous sample types, making it broadly applicable to life science disciplines and applied markets.

With a basic understanding of metabolomics in mind, we will now discuss challenges associated with metabolomics studies, and innovations that Metabolon has developed to address them. We will also discuss Metabolon’s chemical-centric (chemo-centric) approach to data analysis and explain how it elevates the quality of Metabolon-generated data above the rest of the industry.

Metabolomics Guide ebook cover

Download the complete PDF guide

Download this comprehensive guide developed to teach you the ins and outs of one of the most powerful omics tools in any scientist’s toolbox: metabolomics.

Download now

Contact Us

Talk with an expert

Request a quote for our services, get more information on sample types and handling procedures, request a letter of support, or submit a question about how metabolomics can advance your research.

Corporate Headquarters

617 Davis Drive, Suite 100
Morrisville, NC 27560

Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709

+1 (919) 572-1711

+1 (919) 572-1721

International Headquarters

Metabolon GmbH

Zeppelinstraße 3
85399 Hallbergmoos
Germany

+49 89 99017752

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.